Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Development and implementation of competency-based assessment for urological ultrasound training using SonoSim: A preliminary evaluation.

Autor: Rowley KJ; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA., Wheeler KM; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA., Pruthi DK; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA., Mansour AM; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA., Kaushik D; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA., Basler JW; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA., Liss MA; Department of Urology, University of Texas Health San Antonio, San Antonio, TX, USA.

Publikováno v: Indian journal of urology : IJU : journal of the Urological Society of India [Indian J Urol] 2020 Oct-Dec; Vol. 36 (4), pp. 270-275. Date of Electronic Publication: 2020 Oct 01.

Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.

Autor: Budigi Y; Visterra Singapore International Pte Ltd, Singapore, Singapore.; Infectious Diseases Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore, Singapore., Ong EZ; Experimental Therapeutics Centre, Agency for Science, Technology and Research, Singapore, Singapore.; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Robinson LN; Visterra Inc, Cambridge, Massachusetts, United States of America., Ong LC; Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Rowley KJ; Visterra Inc, Cambridge, Massachusetts, United States of America., Winnett A; Visterra Inc, Cambridge, Massachusetts, United States of America., Tan HC; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Hobbie S; Visterra Singapore International Pte Ltd, Singapore, Singapore., Shriver Z; Visterra Inc, Cambridge, Massachusetts, United States of America., Babcock GJ; Visterra Inc, Cambridge, Massachusetts, United States of America., Alonso S; Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Ooi EE; Infectious Diseases Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore, Singapore.; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.; Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Publikováno v: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2018 Feb 09; Vol. 12 (2), pp. e0006209. Date of Electronic Publication: 2018 Feb 09 (Print Publication: 2018).

Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope.

Autor: Robinson LN; Visterra Inc., One Kendall Square, Suite B3301, Cambridge, MA 02139, USA; Department of Biological Engineering, Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge MA 02139; USA., Tharakaraman K; Department of Biological Engineering, Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge MA 02139; USA., Rowley KJ; Visterra Inc., One Kendall Square, Suite B3301, Cambridge, MA 02139, USA., Costa VV; Infectious Diseases Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore., Chan KR; Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857., Wong YH; School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551., Ong LC; Infectious Diseases Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore., Tan HC; Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857., Koch T; Visterra Inc., One Kendall Square, Suite B3301, Cambridge, MA 02139, USA., Cain D; Department of Biological Engineering, Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge MA 02139; USA., Kirloskar R; Department of Biological Engineering, Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge MA 02139; USA., Viswanathan K; Visterra Inc., One Kendall Square, Suite B3301, Cambridge, MA 02139, USA., Liew CW; School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551., Tissire H; Visterra Inc., One Kendall Square, Suite B3301, Cambridge, MA 02139, USA., Ramakrishnan B; Visterra Inc., One Kendall Square, Suite B3301, Cambridge, MA 02139, USA., Myette JR; Visterra Inc., One Kendall Square, Suite B3301, Cambridge, MA 02139, USA., Babcock GJ; Visterra Inc., One Kendall Square, Suite B3301, Cambridge, MA 02139, USA., Sasisekharan V; Department of Biological Engineering, Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge MA 02139; USA., Alonso S; Infectious Diseases Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore; Department of Microbiology, National University of Singapore, 5 Science Drive 2, Blk MD4, Level 3, Singapore 117545., Chen J; Infectious Diseases Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore; Department of Biology, Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge MA 02139, USA., Lescar J; School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive, Singapore 637551., Shriver Z; Visterra Inc., One Kendall Square, Suite B3301, Cambridge, MA 02139, USA., Ooi EE; Infectious Diseases Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore; Program in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857., Sasisekharan R; Department of Biological Engineering, Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge MA 02139; USA; Infectious Diseases Interdisciplinary Research Group, Singapore-MIT Alliance for Research and Technology, Singapore. Electronic address: rams@mit.edu.

Publikováno v: Cell [Cell] 2015 Jul 30; Vol. 162 (3), pp. 493-504. Date of Electronic Publication: 2015 Jul 16.

Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees.

Autor: Morin TJ; MassBiologics, University of Massachusetts Medical School, Boston, Massachusetts, United States of America., Broering TJ, Leav BA, Blair BM, Rowley KJ, Boucher EN, Wang Y, Cheslock PS, Knauber M, Olsen DB, Ludmerer SW, Szabo G, Finberg RW, Purcell RH, Lanford RE, Ambrosino DM, Molrine DC, Babcock GJ

Publikováno v: PLoS pathogens [PLoS Pathog] 2012; Vol. 8 (8), pp. e1002895. Date of Electronic Publication: 2012 Aug 30.